AxoSim
AxoSim’s NerveSim® and BrainSim® platforms are revolutionizing the way that biopharmaceutical companies develop neurological drugs. Our mission is to empower advancements in human neuroscience so that patients in need can get the care they deserve.
Company Ownership:
Socially Disadvantaged
Contact Name:
Lowry Curley
Contact Email:
Website:
https://axosim.com
City, State – Congressional District:
New Orleans,
LA
–
2
Technology:
Research Tool
Funding:
Environmental Health (NIEHS),
Translational Sciences (NCATS)
NIH Projects:
NIH RePorter for
AxoSim
Sponsored Event(s):
Life Sciences Summit | 2020
